Fig. 9
From: Design and characterization of camptothecin gel for treatment of epidermoid carcinoma
![Fig. 9](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs43094-020-00066-6/MediaObjects/43094_2020_66_Fig9_HTML.png)
a Negative control activity on skin cancer cell lines A431. b Anticancer activity of camptothecin gel on skin cancer cell lines A431
From: Design and characterization of camptothecin gel for treatment of epidermoid carcinoma
a Negative control activity on skin cancer cell lines A431. b Anticancer activity of camptothecin gel on skin cancer cell lines A431